Related references
Note: Only part of the references are listed.GABAkines - Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors
Rok Cerne et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Involvement of the GABAA receptor α subunit in the mode of action of etifoxine
Cesar Mattei et al.
PHARMACOLOGICAL RESEARCH (2019)
Human pharmacology of positive GABA-A subtype-selective receptor modulators for the treatment of anxiety
Xia Chen et al.
ACTA PHARMACOLOGICA SINICA (2019)
Input-Specific Synaptic Location and Function of the α5 GABAA Receptor Subunit in the Mouse CA1 Hippocampal Neurons
Elise Magnin et al.
JOURNAL OF NEUROSCIENCE (2019)
GABAA receptor signalling mechanisms revealed by structural pharmacology
Simonas Masiulis et al.
NATURE (2019)
A Review of Alprazolam Use, Misuse, and Withdrawal
Nassima Ait-Daoud et al.
JOURNAL OF ADDICTION MEDICINE (2018)
Valium without dependence? Individual GABAA receptor subtype contribution toward benzodiazepine addiction, tolerance, and therapeutic effects
Tianze Cheng et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2018)
GABA(A) Receptor Subtypes: Therapeutic Potential in Down Syndrome, Affective Disorders, Schizophrenia, and Autism
Uwe Rudolph et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
Mexazolam: Clinical Efficacy and Tolerability in the Treatment of Anxiety
Helder Fernandes et al.
NEUROLOGY AND THERAPY (2014)
Understanding the pharmacokinetics of anxiolytic drugs
Alfredo Carlo Altamura et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Role of α1-and α2-GABAA receptors in mediating the respiratory changes associated with benzodiazepine sedation
S. Masneuf et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Setting the Time Course of Inhibitory Synaptic Currents by Mixing Multiple GABAA Receptor α Subunit Isoforms
Mark D. Eyre et al.
JOURNAL OF NEUROSCIENCE (2012)
Anxioselective anxiolytics: on a quest for the Holy Grail
Phil Skolnick
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
GABAA Receptor Subtype-Selective Modulators. I. α2/α3-Selective Agonists as Non-Sedating Anxiolytics
John R. Atack
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes
Uwe Rudolph et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Hooked on benzodiazepines: GABAA receptor subtypes and addiction
Kelly R. Tan et al.
TRENDS IN NEUROSCIENCES (2011)
International union of pharmacology.: LXX.: Subtypes of γ-aminobutyric AcidA receptors:: Classification on the basis of subunit composition, pharmacology, and function.: Update
Richard W. Olsen et al.
PHARMACOLOGICAL REVIEWS (2008)
Synaptic α5 subunit-containing GABAA receptors mediate IPSPs elicited by dendrite-preferring cells in rat neocortex
Afia B. Ali et al.
CEREBRAL CORTEX (2008)
Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg
Tim R. M. Leufkens et al.
PSYCHOPHARMACOLOGY (2007)
A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers
I Hindmarch et al.
PSYCHOPHARMACOLOGY (2005)
Evidence for a significant role of α3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines
R Dias et al.
JOURNAL OF NEUROSCIENCE (2005)
Analysis of the influence of bromazepam on cognitive performance through the visual evoked potential (P300)
F Puga et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2005)
Psychomotor and anxiolytic effects of mexazolam in patients with generalised anxiety disorder
L Ferreira et al.
CLINICAL DRUG INVESTIGATION (2003)
Effects of Alprazolam on driving ability memory functioning and psychomotor performance: A randomized, placebo-controlled study
JC Verster et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Psychomotor effects of mexazolam vs placebo in healthy volunteers
P Silveira et al.
CLINICAL DRUG INVESTIGATION (2002)
Mexazolam and alprazolam in the treatment of generalised anxiety disorder - A double-blind, randomised clinical trial
A Vaz-Serra et al.
CLINICAL DRUG INVESTIGATION (2001)
Share Paper
